About curcuRouge® Subscriptions
We have started to purchase a subscription for curcuRouge® in our store. We hope you will take advantage of this service. You can also...
top of page
Updating the latest information on studies, developments,
and events related to Therabiopharma Inc.
Jul 12
A new treatise on efficacy of curcuRouge® in COVID-19 patients has been published in the Journal of Health, Population and Nutrition.
On June 24, 2024, a paper on COVID-19 infection in curcuRouge® has been published in the Journal of Health, Population and Nutrition. A...
Jun 6
Seminar on curcuRouge® was held at the 144th Annual Meeting of the Pharmaceutical Society of Japan.
On March 31, 2024, the 144th Annual Meeting of the Pharmaceutical Society of Japan/Sera Bio-Pharma Co. held a luncheon seminar (seminar...
Dec 16, 2023
A new treatise on knee osteoarthritis has been published.
curcuRouge® has succeeded in proofing a potential for treating human knee osteoarthritis, particularly at an early stage.
Jun 12, 2023
Therabiopharma on stage at Kento Innovation Park Talk Session
Our CEO, Mr. Hashimoto, and Professor Kakeya from the Graduate School of Pharmaceutical Sciences at Kyoto University, who is also our...
Sep 3, 2021
A new treatise has been published.(Updated)
Title Newly Developed Highly Bioavailable Curcumin Formulation, curcuRouge™, Reduces Neutrophil/Lymphocyte Ratio in the Elderly: A...
bottom of page